Deutsche Bank Maintains Buy on BioNTech, Raises Price Target to $150
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank analyst Emmanuel Papadakis has maintained a Buy rating on BioNTech (NASDAQ:BNTX) and increased the price target from $95 to $150.
September 19, 2024 | 5:36 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Deutsche Bank has increased its price target for BioNTech from $95 to $150, maintaining a Buy rating. This suggests confidence in BioNTech's future performance.
The increase in price target from $95 to $150 by Deutsche Bank indicates a strong positive outlook on BioNTech's future performance. Maintaining a Buy rating further supports this positive sentiment, likely leading to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100